Skip to search formSkip to main contentSkip to account menu

Myeloid Metaplasia

Known as: METAPLASIA MYELOID 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Serial analysis for the activating JAK2(V617F) mutation performed in 44 patients with myelofibrosis with myeloid metaplasia… 
2001
2001
The anti‐fibrotic and cytokine modulatory properties of pirfenidone suggest its usefulness in the treatment of myelofibrosis with… 
Highly Cited
2000
Highly Cited
2000
Current treatment in myelofibrosis with myeloid metaplasia (MMM) is inadequate: only a small proportion of patients derive… 
Highly Cited
1999
Highly Cited
1999
In a prospective study investigating the therapeutic role of anagrelide in myelofibrosis with myeloid metaplasia, 20 patients… 
Highly Cited
1987
Highly Cited
1987
2 patients with myelofibrosis and myeloid metaplasia had symptomatic splenomegaly and were treated with interferon alpha‐2c (IFN… 
Review
1981
Review
1981
Agnogenic myeloid metaplasia is an uncommon disease included in the myeloproliferative disorders along with polycythemia vera… 
1977
1977
Pyoderma gangrenosum has been associated with myelogenous leukemia and plasma cell dyscrasia. When associated with leukemia… 
1969
1969
Eight patients with metastatic carcinoma with findings simulating agnogenic myeloid metaplasia and myelofibrosis are reported… 
1967
1967
ALTHOUGH chromosome analysis in myeloproliferative disorders has usually confirmed a normal chromosome pattern, several reports… 
1960
1960
Introduction The spleen in myeloid metaplasia is the principal site of extramedullary blood formation. In the past, progressive…